Literature DB >> 2952669

Improved rat model for studying Pneumocystis carinii pneumonia.

M S Bartlett, S F Queener, M A Jay, M M Durkin, J W Smith.   

Abstract

Sprague-Dawley rats treated for 8 weeks with cortisone acetate (25 mg per rat twice weekly) were immunosuppressed to variable degrees. A total of 55% lost over 12% of their initial body weight, had cortisol concentrations in serum more than five times greater than those of the controls, and had markedly depressed ratios of helper to non-helper T cells, in both the spleen and peripheral blood. Animals that gained weight during immunosuppression had cortisol concentrations in serum only three times higher than those of the controls, had normal ratios of helper to non-helper T cells in the spleen, and had only modestly reduced T-cell ratios in peripheral blood. The degree of Pneumocystis pneumonia was evaluated in impression smears and sections of lungs taken from immunosuppressed rats. Pneumocystis infections were more severe in the rats that showed the greatest weight loss. Weight change during immunosuppression may therefore be used as a reliable means for predicting the degree of Pneumocystis infection in living rats. This protocol allows the selection of uniformly infected rats for studies assessing drug therapy of Pneumocystis pneumonia.

Entities:  

Mesh:

Year:  1987        PMID: 2952669      PMCID: PMC265957          DOI: 10.1128/jcm.25.3.480-484.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Studies on adjuvant-induced arthritis, tumor transplantability, and serologic response to bovine serum albumin in Sendai virus-infected rats.

Authors:  L E Garlinghouse; G L Van Hoosier
Journal:  Am J Vet Res       Date:  1978-02       Impact factor: 1.156

2.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

3.  Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.

Authors:  R M Kluge; D M Spaulding; A J Spain
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

4.  Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts.

Authors:  Y Matsumoto; Y Yoshida
Journal:  J Protozool       Date:  1984-08

5.  Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia.

Authors:  P D Walzer; M LaBine; T J Redington; M T Cushion
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

6.  Mechanisms of immunosuppression in cytomegaloviral mononucleosis.

Authors:  C R Rinaldo; W P Carney; B S Richter; P H Black; M S Hirsch
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

7.  Cultivation of Pneumocystis carinii with WI-38 cells.

Authors:  M S Bartlett; P A Verbanac; J W Smith
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

8.  Pneumocystis carinii: electron microscopic investigation on the interaction of trophozoite and alveolar lining cell.

Authors:  Y Yoshida; Y Matsumoto; M Yamada; K Okabayashi; H Yoshikawa; M Nakazawa
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1984-03

9.  Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.

Authors:  W T Hughes; B L Smith; D P Jacobus
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

View more
  8 in total

1.  Models for evaluating compounds for activity against Pneumocystis carinii.

Authors:  M S Bartlett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

2.  Chronic oral administration of dexamethasone to rats increases cytotoxicity, but not interleukin-1 elaboration, by alveolar macrophages.

Authors:  J M Beck; V V Suzara; J Shellito
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.

Authors:  S F Queener; M S Bartlett; J D Richardson; M M Durkin; M A Jay; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

4.  New rat model of Pneumocystis carinii infection.

Authors:  M S Bartlett; J A Fishman; S F Queener; M M Durkin; M A Jay; J W Smith
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

5.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats.

Authors:  Scott P Keely; Melanie T Cushion; James R Stringer
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.

Authors:  R M Perenboom; W J Oyen; A C van Schijndel; P Beckers; F H Corstens; J W van der Meer
Journal:  Eur J Nucl Med       Date:  1995-10

8.  Sources of rats free of latent Pneumocystis carinii.

Authors:  M S Bartlett; M M Durkin; M A Jay; S F Queener; J W Smith
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.